The expression of these proteins correlated with tumor areas in which cells had more “active” appearing nuclear features, and high expression of ADAM12, FAP, and WISP1, and low expression of SOX11, correlated with worse clinical outcome. The gene discussed is ADAM12; the disease is neoplasm.